The European Society for Vascular Surgery (ESVS) has produced a clinical practice guidelines document on the management of venous thrombosis—the first guidelines the society have produced on this topic. The document was published as an Editor’s Choice paper in the January issue of the European Journal of Vascular and Endovascular Surgery (EJVES).
The guidelines document “addresses acute deep vein thrombosis (DVT) of the lower extremities […], upper extremity DVT, superficial vein thrombosis (SVT), and thrombosis in unusual sites,” the Guidelines Writing Committee relay. They add that the document “also covers topics in addition to treatments, including investigations and health economics, and includes special patient populations”.
The authors write that the topic of venous thrombosis is large, and therefore state that “the remit of the guideline committee has been limited to conditions and situations likely to be commonly encountered by clinical teams/end users managing patients with venous thrombosis and others exposed to this condition”.
As well as a detailing a series of recommendations, the document also identifies a series of unresolved issues in the field, where further research “may help the decision-making process and better guide clinical practice”. These include the cause of racial disparities in the incidence of DVT, the use of an inferior vena cava (IVC) filter for the treatment of patients with DVT in whom anticoagulation is contraindicated, and the effectiveness of intermediate doses of low-molecular-weight heparin versus placebo in reducing venous thromboembolism in SVT patients.
Regarding the Guidelines Writing Committee, it is stated in the document that this consisted mainly of ESVS members, and also “eminent thrombosis experts from other societies with relevant clinical experience, strong publication records, and academic profiles”.
Read the full guidelines document here.